didanosine

Objective To find out the alterations of the immunological and virological indexes and the emergence of resistant strains in the patients undergoing anti-HIV therapy ( receiving Zidovudine, Didanosine and Nevirapine).

目的了解确山县抗艾滋病病毒（HIV）治疗过程中，接受治疗（治疗方案为齐多夫定胶囊、去羟基甘散和奈韦拉平片）的患者的免疫学和病毒学指标的变化和耐药毒株的出现情况。

Pharmacokinetics of domestic didanosine enteric capsules in healthy Chinese young men

国产去羟肌苷肠溶胶囊在中国健康男青年体内药物动力学研究

Of patients receiving two-year antiretroviral treatment, 48.2 per cent showed signs of drug resistance against a common combination of drugs Zidovudine, Didanosine and Nevirapine.

这些接受了两年抗转录病毒治疗的患者中，有48.2%的患者对常见的鸡尾酒疗法组合齐多夫定（AZT）、去羟基昔（DDI）和奈韦拉平（NVP）的组方治疗显示出了耐药性。

Fatal lactic acidosis has been reported to patients who received didanosine and other antiretroviral agents.

有报道同时应用核苷类似物的患者可能发生乳酸酸中毒,有时是致命的.

Didanosine, Stavudine and Nevirapine in 20 cases of AIDS patients

去羟肌苷、司他夫定联合奈韦拉平治疗艾滋病患者临床观察

Quantitative Analyses of Didanosine and Stavudine in Human Plasma and Their Applications

去羟肌苷和司他夫定血浆样品定量分析方法的研究和应用

The first 6-months evaluation on the efficacy of combined therapy with didanosine, stavudine and nevirapine in AIDS patients

去羟肌苷散、司他夫定和奈韦拉平联合治疗艾滋病患者6个月疗效观察